Bactolife A/s

This study is the first time a new food ingredient, BP-CBB, is being tested in people. The goal is to check its safety and how well people tolerate taking it once a day. Sixty healthy adults aged 18 to 65 will take either BP-CBB or a placebo for a period of time. This study does …

This study follows 60 adults who have had a C. diff infection return after standard antibiotic treatment. Researchers want to see how often the infection comes back within 8 weeks and whether measuring toxin levels in stool can predict that risk. Participants provide stool sample…